Expert Columns by Sheela Ranganathan - O'Neill : O'Neill

Opinion & Analysis

November 20, 2024

Pharmaceutical Industry Seeks to Thwart State Initiatives to Tackle Unaffordability of Prescription Drugs

Opinion & Analysis

May 8, 2024

Threats to EMTALA: Unpacking the Oral Arguments in Idaho v. United States

Opinion & Analysis

March 7, 2024

No Surprises Act Litigation: Where We Are and What Comes Next

Opinion & Analysis

February 1, 2024

Unpacking Recent Antitrust Challenges to Private Equity in Health Care

Opinion & Analysis

November 20, 2023

Latest Development in Legal Challenges to Arbitration Process Under No Surprises Act

Sheela Ranganathan Associate

The Latest

Statement

January 21, 2025

Statement from the O’Neill Institute for National and Global Health Law on the United States’ Withdrawal from the World Health Organization

Op-Ed

January 17, 2025

A World Without WHO—A Crossroads for US Global Health Leadership

Op-Ed

January 16, 2025

‘Divisive Concepts’ Prohibitions: Implications For Health And Health Equity